Enovis (ENOV)
Enovis on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, financials, earnings dates and insider trades. Listed on NYSE, classified by the SEC as orthopedic, prosthetic & surgical appliances & supplies.
10.6M
Short interest
settlement 2026-09-30
5.8
Days to cover
+2.2 days vs prior
60.6%
Short share of volume
2026-10-09
1,456
Fails to deliver
settlement 2026-09-01
Thu 5 Nov
Next earnings
estimated date
$450K
Insider flow, 90 days
4 buys, 0 sells
As of 2026-10-09.
Short interest
FINRA, twice a month. The newest 24 settlements in the table, 48 in the chart. JSONAs of 30 September 2026, short interest in ENOV is 10,561,633 shares, up 1,467,047 shares over the last month. Over the last 48 readings it ranged from 4,167,339 shares (13 December 2024) to 10,561,633 shares (30 September 2026). The latest reading sits at the top of that range. At the reported average volume of 1.8M shares a day that is 5.8 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/enov" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-09-30 | 10,561,633 | +11.4% | 1,836,233 | 5.75 |
| 2026-09-15 | 9,483,247 | +4.3% | 2,693,327 | 3.52 |
| 2026-08-31 | 9,094,586 | +4.4% | 657,863 | 13.82 |
| 2026-08-14 | 8,712,564 | +2.0% | 1,531,959 | 5.69 |
| 2026-07-31 | 8,541,676 | +2.4% | 925,509 | 9.23 |
| 2026-07-15 | 8,342,206 | -12.2% | 1,264,074 | 6.60 |
| 2026-06-30 | 9,495,565 | +4.9% | 1,362,767 | 6.97 |
| 2026-06-15 | 9,048,630 | +4.6% | 1,058,200 | 8.55 |
| 2026-05-29 | 8,653,272 | +3.0% | 1,080,471 | 8.01 |
| 2026-05-15 | 8,404,214 | -8.9% | 1,304,511 | 6.44 |
| 2026-04-30 | 9,230,699 | +7.5% | 1,002,525 | 9.21 |
| 2026-04-15 | 8,583,333 | +5.3% | 600,208 | 14.30 |
| 2026-03-31 | 8,148,419 | +2.5% | 856,345 | 9.52 |
| 2026-03-13 | 7,952,990 | -1.0% | 1,053,031 | 7.55 |
| 2026-02-27 | 8,035,071 | -7.3% | 1,376,457 | 5.84 |
| 2026-02-13 | 8,667,937 | -0.6% | 1,089,910 | 7.95 |
| 2026-01-30 | 8,716,877 | +7.1% | 1,064,879 | 8.19 |
| 2026-01-15 | 8,139,354 | +2.7% | 1,143,265 | 7.12 |
| 2025-12-31 | 7,924,009 | -5.9% | 841,434 | 9.42 |
| 2025-12-15 | 8,422,648 | -0.0% | 949,409 | 8.87 |
| 2025-11-28 | 8,424,563 | +8.7% | 730,783 | 11.53 |
| 2025-11-14 | 7,754,149 | +0.4% | 1,045,997 | 7.41 |
| 2025-10-31 | 7,722,180 | +7.7% | 635,633 | 12.15 |
| 2025-10-15 | 7,170,793 | -0.4% | 629,515 | 11.39 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 9 October 2026, the short share of ENOV volume is 60.6%, down 0.2 points over the last five sessions. Over the last 30 readings it ranged from 39.5% (21 September 2026) to 71.9% (1 October 2026). The latest reading is 4.3 points above the 30-session average of 56.3%, on 374K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-09 | 227K | 374K | 60.6% | 0 |
| 2026-10-08 | 411K | 592K | 69.5% | 228 |
| 2026-10-07 | 240K | 464K | 51.6% | 0 |
| 2026-10-06 | 264K | 392K | 67.2% | 8 |
| 2026-10-05 | 317K | 498K | 63.7% | 0 |
| 2026-10-02 | 272K | 448K | 60.8% | 100 |
| 2026-10-01 | 259K | 360K | 71.9% | 0 |
| 2026-09-30 | 176K | 324K | 54.5% | 373 |
| 2026-09-29 | 252K | 412K | 61.2% | 582 |
| 2026-09-28 | 187K | 309K | 60.6% | 0 |
| 2026-09-25 | 189K | 350K | 54.1% | 0 |
| 2026-09-24 | 354K | 682K | 51.8% | 0 |
| 2026-09-23 | 294K | 438K | 67.0% | 20 |
| 2026-09-22 | 293K | 643K | 45.5% | 0 |
| 2026-09-21 | 351K | 889K | 39.5% | 17,516 |
| 2026-09-18 | 328K | 592K | 55.5% | 3,063 |
| 2026-09-17 | 615K | 910K | 67.6% | 454 |
| 2026-09-16 | 557K | 822K | 67.8% | 0 |
| 2026-09-15 | 453K | 1.0M | 44.2% | 200 |
| 2026-09-14 | 473K | 1.2M | 39.9% | 2 |
| 2026-09-11 | 502K | 1.1M | 45.7% | 0 |
| 2026-09-10 | 495K | 833K | 59.4% | 0 |
| 2026-09-09 | 402K | 822K | 48.9% | 9,319 |
| 2026-09-08 | 710K | 1.6M | 43.8% | 80 |
| 2026-09-04 | 344K | 845K | 40.7% | 129 |
| 2026-09-03 | 680K | 1.2M | 57.9% | 0 |
| 2026-09-02 | 553K | 1.2M | 44.3% | 28,620 |
| 2026-09-01 | 1.2M | 1.7M | 67.5% | 23,730 |
| 2026-08-31 | 177K | 262K | 67.5% | 0 |
| 2026-08-28 | 83K | 140K | 59.2% | 51 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 1 September 2026, the fails-to-deliver balance in ENOV is 1,456 shares, down 36,223 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (17 August 2026) to 152,836 shares (23 June 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-01 | 1,456 | $24.59 | $36K |
| 2026-08-27 | 37,679 | $25.25 | $951K |
| 2026-08-19 | 106 | $25.64 | $3K |
| 2026-08-17 | 1 | $26.06 | $26 |
| 2026-08-10 | 2,400 | $26.61 | $64K |
| 2026-08-07 | 335 | $26.31 | $9K |
| 2026-08-06 | 4 | $30.18 | $121 |
| 2026-08-04 | 147 | $31.42 | $5K |
| 2026-07-31 | 115 | $29.30 | $3K |
| 2026-07-30 | 1,281 | $30.26 | $39K |
| 2026-07-28 | 2 | $28.25 | $57 |
| 2026-07-27 | 1,139 | $27.03 | $31K |
| 2026-07-22 | 87 | $27.10 | $2K |
| 2026-07-21 | 857 | $26.84 | $23K |
| 2026-07-17 | 559 | $28.07 | $16K |
| 2026-07-16 | 123 | $25.59 | $3K |
| 2026-07-13 | 3 | $25.75 | $77 |
| 2026-07-10 | 64 | $25.22 | $2K |
| 2026-07-08 | 366 | $25.52 | $9K |
| 2026-07-07 | 1,916 | $25.90 | $50K |
| 2026-07-06 | 763 | $22.50 | $17K |
| 2026-07-02 | 500 | $20.04 | $10K |
| 2026-07-01 | 660 | $20.70 | $14K |
| 2026-06-30 | 22,508 | $22.02 | $496K |
| 2026-06-29 | 19,802 | $22.71 | $450K |
| 2026-06-24 | 2,100 | $21.15 | $44K |
| 2026-06-23 | 152,836 | $21.30 | $3.3M |
| 2026-06-22 | 38,980 | $21.97 | $856K |
| 2026-06-16 | 1,006 | $20.98 | $21K |
| 2026-06-15 | 14 | $21.80 | $305 |
Insider trades
SEC Form 4, newest first, 50 of 100 shown. JSONInsiders at ENOV reported 4 open-market buys worth $450K in the last 90 days and no open-market sells. Latest filing: Ortiz Christine (Director) on 2026-09-30.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | Ortiz Christine | Director | Grant | 958 | $0.00 | $0 | 27K |
| 2026-09-04 | Engert Oliver | Chief Administrative Officer | Buy | 3K | $18.80 | $50K | 64K |
| 2026-09-04 | McDonald Damien | Chief Executive Officer | Buy | 13K | $19.15 | $250K | 247K |
| 2026-09-03 | Engert Oliver | Chief Administrative Officer | Buy | 5K | $19.46 | $100K | 61K |
| 2026-09-02 | Engert Oliver | Chief Administrative Officer | Buy | 2K | $20.32 | $50K | 56K |
| 2026-06-30 | Ortiz Christine | Director | Grant | 846 | $0.00 | $0 | 26K |
| 2026-06-15 | Engert Oliver | Chief Administrative Officer | Buy | 1K | $20.92 | $21K | 54K |
| 2026-06-11 | Engert Oliver | Chief Administrative Officer | Buy | 200 | $20.99 | $4K | 51K |
| 2026-06-11 | Engert Oliver | Chief Administrative Officer | Buy | 1K | $21.75 | $22K | 52K |
| 2026-06-11 | Engert Oliver | Chief Administrative Officer | Grant | 1K | $20.99 | $21K | 53K |
| 2026-06-10 | Engert Oliver | Chief Administrative Officer | Buy | 1K | $23.00 | $23K | 51K |
| 2026-06-01 | Engert Oliver | Chief Administrative Officer | Buy | 1K | $22.22 | $22K | 50K |
| 2026-05-19 | Shirley Brady | Director | Grant | 9K | $0.00 | $0 | 111K |
| 2026-05-19 | Okala Philip | Director | Grant | 9K | $0.00 | $0 | 24K |
| 2026-05-19 | Ortiz Christine | Director | Grant | 9K | $0.00 | $0 | 25K |
| 2026-05-19 | Lalor Angela S | Director | Grant | 9K | $0.00 | $0 | 31K |
| 2026-05-19 | PERFALL A CLAYTON | Director | Grant | 9K | $0.00 | $0 | 54K |
| 2026-05-19 | Kelly Liam | Director | Grant | 9K | $0.00 | $0 | 29K |
| 2026-05-19 | Wienbar Sharon L | Director | Grant | 9K | $0.00 | $0 | 42K |
| 2026-05-19 | Vinnakota Rajiv | Director | Grant | 9K | $0.00 | $0 | 38K |
| 2026-05-19 | Bodem Barbara W. | Director | Grant | 9K | $0.00 | $0 | 24K |
| 2026-05-12 | McDonald Damien | Chief Executive Officer | Tax withholding | 13K | $25.99 | $328K | 234K |
| 2026-05-12 | BERRY PHILLIP BENJAMIN (BEN) | SVP, Chief Financial Officer | Tax withholding | 8K | $25.99 | $202K | 151K |
| 2026-03-31 | Ortiz Christine | Director | Grant | 770 | $0.00 | $0 | 16K |
| 2026-03-13 | Engert Oliver | Chief Administrative Officer | Buy | 1K | $23.74 | $24K | 49K |
| 2026-03-10 | Engert Oliver | Chief Administrative Officer | Buy | 1K | $23.93 | $24K | 48K |
| 2026-03-09 | KLECKNER JOHN | Principal Accounting Officer | Grant | 15K | $0.00 | $0 | 26K |
| 2026-03-09 | ROSS TERRY D | GROUP PRESIDENT, P&R | Grant | 36K | $0.00 | $0 | 68K |
| 2026-03-09 | Lang Patricia A | SVP, Chief HR Officer | Grant | 26K | $0.00 | $0 | 76K |
| 2026-03-09 | VOGT LOUIS | GROUP PRESIDENT, RECON | Grant | 36K | $0.00 | $0 | 69K |
| 2026-03-09 | Tandy Bradley J | SVP and Chief Legal Officer | Grant | 26K | $0.00 | $0 | 66K |
| 2026-03-09 | McDonald Damien | Chief Executive Officer | Grant | 144K | $0.00 | $0 | 247K |
| 2026-03-09 | Engert Oliver | Chief Administrative Officer | Buy | 1K | $23.39 | $23K | 47K |
| 2026-03-09 | BERRY PHILLIP BENJAMIN (BEN) | SVP, Chief Financial Officer | Grant | 48K | $0.00 | $0 | 159K |
| 2026-03-07 | KLECKNER JOHN | Principal Accounting Officer | Tax withholding | 586 | $24.51 | $14K | 11K |
| 2026-03-07 | ROSS TERRY D | GROUP PRESIDENT, P&R | Tax withholding | 2K | $24.51 | $58K | 32K |
| 2026-03-07 | Lang Patricia A | SVP, Chief HR Officer | Tax withholding | 3K | $24.51 | $73K | 50K |
| 2026-03-07 | VOGT LOUIS | GROUP PRESIDENT, RECON | Tax withholding | 2K | $24.51 | $49K | 33K |
| 2026-03-07 | Tandy Bradley J | SVP and Chief Legal Officer | Tax withholding | 2K | $24.51 | $46K | 40K |
| 2026-03-07 | BERRY PHILLIP BENJAMIN (BEN) | SVP, Chief Financial Officer | Tax withholding | 3K | $24.51 | $78K | 111K |
| 2026-03-06 | Engert Oliver | Chief Administrative Officer | Buy | 500 | $24.48 | $12K | 46K |
| 2026-03-06 | Engert Oliver | Chief Administrative Officer | Buy | 250 | $24.28 | $6K | 45K |
| 2026-03-04 | Engert Oliver | Chief Administrative Officer | Buy | 250 | $25.10 | $6K | 45K |
| 2026-03-04 | Tandy Bradley J | SVP and Chief Legal Officer | Tax withholding | 1K | $25.79 | $28K | 42K |
| 2026-03-04 | ROSS TERRY D | GROUP PRESIDENT, P&R | Tax withholding | 765 | $25.79 | $20K | 35K |
| 2026-03-04 | KLECKNER JOHN | Principal Accounting Officer | Tax withholding | 442 | $25.79 | $11K | 12K |
| 2026-03-04 | Shirley Brady | Director | Tax withholding | 3K | $25.79 | $79K | 101K |
| 2026-03-04 | VOGT LOUIS | GROUP PRESIDENT, RECON | Tax withholding | 888 | $25.79 | $23K | 35K |
| 2026-03-04 | Lang Patricia A | SVP, Chief HR Officer | Tax withholding | 1K | $25.79 | $30K | 53K |
| 2026-03-04 | BERRY PHILLIP BENJAMIN (BEN) | SVP, Chief Financial Officer | Tax withholding | 2K | $25.79 | $57K | 114K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON5 holders report 5% or more of ENOV in their latest filing, all on Schedule 13G (passive). The largest reported stake is BlackRock, Inc. at 16.0% of the class (9,181,052 shares), filed 2026-07-28 for an event on 2026-06-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-14 | 13G | David Rosenparent holding company, individual | 3.9M | 6.8% | 2026-06-30 |
| 2026-08-14 | 13G | Rubric Capital Management LPinvestment adviser, partnership | 3.9M | 6.8% | 2026-06-30 |
| 2026-07-28 | 13G/Ano. 6 | BlackRock, Inc.parent holding company | 9.2M | 16.0% | 2026-06-30 |
| 2026-04-29 | 13G | Vanguard Portfolio Managementinvestment adviser | 3.9M | 6.8% | 2026-03-31 |
| 2026-04-29 | 13G | Vanguard Capital Managementinvestment adviser | 3.0M | 5.2% | 2026-03-31 |
| 2026-03-26 | 13G/Ano. 9 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2026-01-21 | 13G/Ano. 2 | Dimensional Fund Advisors LPinvestment adviser | 2.8M | 4.9% | 2025-12-31 |
13F holders
Tracked managers holding ENOV at their latest 13F. JSON4 of the 30 tracked managers held ENOV at their latest 13F, $32.2M in total at quarter-end prices. Millennium Management is the largest at $16.6M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 3 added shares and 1 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Millennium Management | 2026-06-30 | 803K | $16.6M | 0.01% | +174K |
| AQR Capital Management | 2026-06-30 | 591K | $12.2M | 0.00% | +307K |
| D. E. Shaw & Co. | 2026-06-30 | 84K | $1.7M | 0.00% | -18K |
| Bridgewater Associates | 2026-06-30 | 77K | $1.6M | 0.01% | +26K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 FY 2026 (quarter ended 2026-07-03) Enovis reported revenue of $582.8M, up 3.2% from the same quarter a year earlier, and net loss of $1.2M (-0.02 diluted EPS). In FY 2025 it generated $217.3M of operating cash flow and spent $3.5M on buybacks. As of 2026-07-03, cash was $12.6M against $1.28B of debt.
- Cash
- $12.6M
- Debt
- $1.28B
- Equity
- $1.48B
- Total assets
- $3.77B
- Shares outstanding
- 57,669,494
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-07-03 | $582.8M | -$1.2M | -0.2% | -0.02 |
| Q1 FY 2026 | 2026-04-03 | $589.2M | -$8.8M | -1.5% | -0.15 |
| Q4 FY 2025derived | 2025-12-31 | $575.8M | -$520.6M | -90.4% | n/a |
| Q3 FY 2025 | 2025-10-03 | $548.9M | -$571.1M | -104.1% | -9.99 |
| Q2 FY 2025 | 2025-07-04 | $564.5M | -$36.7M | -6.5% | -0.64 |
| Q1 FY 2025 | 2025-04-04 | $558.8M | -$56.0M | -10.0% | -0.98 |
| Q4 FY 2024derived | 2024-12-31 | $561.0M | -$703.3M | -125.4% | n/a |
| Q3 FY 2024 | 2024-09-27 | $505.2M | -$31.5M | -6.2% | -0.58 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $2.25B | -$1.18B | $217.3M | $197.4M | $3.5M | n/a |
| FY 2024 | 2024-12-31 | $2.11B | -$825.5M | $113.5M | $180.7M | $4.8M | n/a |
| FY 2023 | 2023-12-31 | $1.71B | -$33.3M | $135.0M | $122.2M | $0 | n/a |
| FY 2022 | 2022-12-31 | $1.56B | -$13.3M | -$55.9M | $105.5M | $0 | n/a |
| FY 2021 | 2021-12-31 | $1.43B | $71.7M | $356.1M | $104.2M | n/a | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-07-03; shares outstanding as of 2026-07-31 from the cover page.
What this page is
Enovis in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Enovis (ENOV), SEC CIK 1420800, listed on NYSE, classified by the SEC as orthopedic, prosthetic & surgical appliances & supplies. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-09.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-01.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-14.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-07-03.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-06.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-09-30.JSON and CSV
- Company record
- EDGAR filing index for CIK 1420800Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as orthopedic, prosthetic & surgical appliances & supplies
Other company pages
Datasets
Frequently Asked Questions
How much of ENOV is sold short?
What is ENOV's daily short volume?
Does ENOV have fails to deliver?
Are ENOV insiders buying or selling?
Who owns 5% or more of ENOV?
What did ENOV report last quarter?
Which tracked 13F managers own ENOV?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.